[1]蒋 莹,高 天△,戴军霞.灌肠消炎方辅助西药治疗慢性盆腔炎疗效及对患者血液流变学、血清炎症因子水平的影响*[J].陕西中医,2020,(8):1091.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.020]
 JIANG Ying,GAO Tian,DAI Junxia..Efficacy of enema Xiaoyan prescription supplemented with western medicine on chronic pelvic inflammatory disease and its influence on hemorheology and serum inflammatory factors[J].,2020,(8):1091.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.020]
点击复制

灌肠消炎方辅助西药治疗慢性盆腔炎疗效及对患者血液流变学、血清炎症因子水平的影响*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年8期
页码:
1091
栏目:
临床研究
出版日期:
2020-08-05

文章信息/Info

Title:
Efficacy of enema Xiaoyan prescription supplemented with western medicine on chronic pelvic inflammatory disease and its influence on hemorheology and serum inflammatory factors
作者:
蒋 莹1高 天2△戴军霞3
1.四川省宜宾市第四人民医院妇产科(宜宾 644000); 2.重庆医科大学附属第一医院(重庆 400016); 3.四川省宜宾市高县沙河中心医院(宜宾 644000)
Author(s):
JIANG YingGAO TianDAI Junxia.
Department of Obstetrics and Gynecology,Yibin No.4 People's Hospital,Sichuan(Yibin 644000)
关键词:
慢性盆腔炎 灌肠消炎方 血液流变学 血清炎性因子 中医证候积分 白介素
Keywords:
Chronic pelvic inflammatory disease Enema Xiaoyan prescription Hemorheology Serum inflammatory factors TCM syndromes scores IL
分类号:
R711.33
DOI:
DOI:10.3969/j.issn.1000-7369.2020.08.020
文献标志码:
A
摘要:
目的:探讨灌肠消炎方辅助西药治疗慢性盆腔炎疗效及对患者血液流变学、血清炎症因子水平的影响。方法:采用随机数字表法将122例慢性盆腔炎患者分为联合组与对照组各61例。对照组患者给予常规西药治疗,联合组患者在此基础上联合使用灌肠消炎方治疗。记录两组患者临床疗效,比较治疗前、治疗2周后两组患者中医证候积分(下腹痛、月经不调、白带异常、腰骶酸痛、疲软无力、行经腹痛加重)、血液流变学[全血高切黏度、全血低切黏度、红细胞沉降率(ESR)、纤维蛋白原(FIB)]及血清炎性因子[白介素-2(IL-2)、白介素-10(IL-10)、转化生长因子(TGF-β1)、单核细胞趋化因子(MCP-1)]水平的变化情况。结果:治疗2周后,联合组患者临床总有效率明显高于对照组(P<0.05); 两组患者中医证候积分均低于治疗前,且联合组明显低于同期对照组(P<0.05); 两组患者全血高切黏度、全血低切黏度、ESR、FIB水平较治疗前均明显降低,联合组低于同期对照组(P<0.05); 两组患者IL-2、IL-10水平均高于治疗前,且联合组高于对照组(P<0.05); 两组患者TGF-β1、MCP-1明显低于治疗前,且联合组明显低于同期对照组水平(P<0.05)。结论:灌肠消炎方辅助西药治疗慢性盆腔炎疗效显著,能有效减轻患者临床症状,改善血液流变学。
Abstract:
Objective:To explore the efficacy of TCM enema Xiaoyan prescription supplemented with western medicine in the treatment of chronic pelvic inflammatory disease and its influence on hemorheology and serum inflammatory factors.Methods:A total of 122 patients with chronic pelvic inflammatory disease were divided into combined group and control group according to the random number table method,with 61 cases in each group.Patients in control group were treated with conventional western medicine,and patients in combined group were combined with TCM enema Xiaoyan prescription on this basis.The clinical efficacy was recorded in the two groups,and the TCM syndromes scores(lower abdominal pain,irregular menstruation,abnormal leucorrhea,lumbosacral pain,fatigue,increased abdominal pain during menstruation),hemorheology [whole blood high-shear viscosity,whole blood low-shear viscosity,erythrocyte sedimentation rate(ESR),fibrinogen(FIB)] and serum inflammatory factors [Interleukin-2(IL-2),Interleukin-10(IL-10),transforming growth factor(TGF-β1),monocyte chemotactic factor(MCP-1)] were compared between the two groups before treatment and after 2 weeks of treatment.Results:After 2 weeks of treatment,the total clinical effective rate in combined group was significantly higher than that in control group(P<0.05).The TCM syndromes scores in the two groups were lower than those before treatment,and the scores in combined group were significantly lower than those in control group at the same period(P<0.05).The levels of whole blood high-shear viscosity,whole blood low-shear viscosity,ESR and FIB in the two groups were significantly lower than those before treatment,and the levels in combined group were lower than those in control group at the same time period(P<0.05).The levels of IL-2 and IL-10 in the two groups were higher than those before treatment,and the levels in combined group were higher than those in control group(P<0.05).The levels of TGF-β1 and MCP-1 in the two groups were significantly lower than those before treatment,and the levels in combined group were significantly lower than those in control group at the same time period(P<0.05).Conclusion:TCM enema Xiaoyan prescription supplemented with western medicine has a significant efficacy in the treatment of chronic pelvic inflammatory disease,and can effectively relieve the clinical symptoms,improve hemorheology and reduce the serum inflammatory factors.

参考文献/References:

[1] 高 妍.左氧氟沙星甲硝唑联合康妇消炎栓治疗盆腔炎性疾病后遗症的效果[J].中国药物与临床,2019,19(12):2070-2071.
[2] 韩 喆,韩 超,曲淑君.高压氧联合中西医结合治疗慢性盆腔炎性疾病66例疗效观察[J].中华航海医学与高气压医学杂志,2016,23(3):239-240.
[3] 李春香,王春燕,武淑霞.桂枝茯苓丸辅助抗生素治疗慢性盆腔炎的临床疗效观察[J].世界中医药,2016,11(7):1257-1260.
[4] 中华医学会妇产科学分会感染性疾病协作组.盆腔炎症性疾病诊治规范(修订版)[J].中华妇产科杂志,2014,49(6):401-403.
[5] 国家食品药品监督管理总局.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:243-253.
[6] 魏光绪,彭太华,史 传.活血化瘀法联合西药治疗慢性盆腔炎的疗效及对炎性因子的影响[J].河北医学,2015,5(5):719-722.
[7] 李召梅.桂枝茯苓丸联合克林霉素磷酸酯治疗慢性盆腔炎的临床研究[J].现代药物与临床,2016,31(11):1768-1771.
[8] 苏 晨,张健新,周 涛.针刺结合温针灸和电针治疗盆腔炎后遗性疼痛的临床疗效观察[J].中国疼痛医学杂志,2018,24(6):475-477.
[9] 吴晓倩,赵丹丹.行血养心中药治疗心瓣膜置换术后气虚血瘀证疗效及对血液流变学和凝血功能的影响[J].现代中西医结合杂志,2017,26(13):1399-1402.
[10] 高艳霞,薛惠英,刘现红.疏肝养血汤联合西药盆腔灌注治疗慢性盆腔炎疗效及对患者血流变、免疫功能的影响[J].陕西中医,2018,39(11):1576-1579.
[11] 赵志梅,张立杰,夏 天,等.莪术主要单体成分抗炎、抗肿瘤作用研究进展[J].药物评价研究,2017,40(1):124.
[12] 黄发婷,梁 漫,孙志圣.盆腔灌注联合TDP治疗慢性盆腔炎临床疗效研究[J].陕西医学杂志,2019,48(2):205-207.
[13] 蔡永青,胡建辉,李小丽.炎症因子调节细胞自噬的研究进展[J].免疫学杂志,2016,32(9):821-824.
[14] 纵艳艳,陈衍秋,胡赛玲.中西医结合治疗慢性盆腔炎合并盆腔积液的临床分析[J].中华全科医学,2016,14(6):1059-1060.
[15] 周秀萍,李争鸣,刘志杰,等.金银花对大鼠免疫功能影响的研究[J].实用预防医学,2011,18(2):26-28.
[16] 尤彩兰.盆腔炎汤保留灌肠联合小剂量氟罗沙星治疗慢性盆腔炎临床疗效研究[J].西部中医药,2018,31(10):100-102.

相似文献/References:

[1]奚向东,明红钰,张 倩.腹骶部“蜻蜓点水”偶刺联合拔罐治疗慢性盆腔炎临床研究*[J].陕西中医,2019,(12):1771.
[2]张春玲,马 颖,孙仲函,等.芪地膝黄桂苓汤治疗慢性盆腔炎疗效及对患者炎性因子和免疫功能的影响[J].陕西中医,2022,(1):41.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.009]
 ZHANG Chunling,MA Ying,SUN Zhonghan,et al.Qidixihuang Guiling decoction on chronic pelvic inflammation and its influence on inflammatory factors and immune function[J].,2022,(8):41.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.009]
[3]许海莺,杨喜乐,李 恒,等.涤痰逐瘀方联合左氧氟沙星治疗慢性盆腔炎疗效及对患者血液流变学、应激与中医证候评分的影响[J].陕西中医,2022,(4):457.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.011]
 XU Haiying,YANG Xile,LI Heng,et al.Effect of Ditan Zhuyu decoction combined with levofloxacin on chronic pelvic inflammation,hemorheology,stress and TCM syndrome score[J].,2022,(8):457.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.011]
[4]王 静,吴绘春,黄艳辉,等.四黄散外敷联合盆炎方口服对慢性盆腔炎患者下腹疼痛、超敏C反应蛋白及血沉水平的影响[J].陕西中医,2023,(6):734.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.011]
 WANG Jing,WU Huichun,HUANG Yanhui,et al.Sihuang powder combined with Penyan formula on lower abdominal pain,hypersensitive C-reactive protein and erythrocyte sedimentation rate in patients with chronic pelvic inflammation[J].,2023,(8):734.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.011]

备注/Memo

备注/Memo:
*重庆市科技惠民计划项目(CSTC2016KJHMPT1001-3)
更新日期/Last Update: 2020-08-10